Listing in London – King & Spalding carries US biotech to AIM listing Legal Business11 May 2015Corporate and M&AUS King & Spalding’s recent recruits in the City have helped handle Californian biotech company Verseon £300m stock market listing in London while Covington & Burling advised from San Francisco.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryTrading Places: Ropes hires Freshfields levfin co-head as top Kirkland litigator retiresFreshfields and Covington advise as Merck acquires US biotech company Terns for $6.7bnPassing judgement: how clients rate London’s top commercial litigation teams‘The merger is working’ – HSF Kramer on its US corporate pushQuality over quantity: fewer deals, bigger bets define the first quarter of 2026Knights in merger talks to create £200m firmClifford Chance names Cohen first New York managing partner amid fresh bid to crack America with Houston office openingInternational Women’s Day 2022: Barbara L. Becker, chair & managing partner, Gibson Dunn, New YorkInternational Women’s Day 2022: Perlette Jura, Gibson Dunn, Los Angeles – disputes